Inventor
Christopher J. Kirk
Inventor
San Francisco, CA, US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes41%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations41%
C07KPeptides6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
PatentTitleYear
10,870,889Immunoglobulin expression levels as biomarker for proteasome inhibitor response202010,662,479Immunoglobulin expression levels as biomarker for proteasome inhibitor response2020RE047954Combination therapy with peptide epoxyketones202010,596,222Combination therapy with peptide epoxyketones202010,022,326Liposomal compositions of epoxyketone-based proteasome inhibitors20189,511,109'Combination therapy with peptide epoxyketones'20169,295,708'Modified release formulations for oprozomib'20168,853,147'Use of peptide epoxyketones for metastasis suppression'2014Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2014–2020Patents assigned to ONYX THERAPEUTICS INC (7)· patent assignee history
2014Patents assigned to JIANG JING (1)· patent assignee history
2014Patents assigned to KIRK CHRISTOPHER J (1)· patent assignee history
2014–2020Based in San Francisco, CA, US· patent location history
2016Based in Millbrae, CA, US· patent location history
2018Based in Milbrae, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ONYX THERAPEUTICS INC | 7 | 2014–2020 |
| JIANG JING | 1 | 2014 |
| KIRK CHRISTOPHER Jself | 1 | 2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 6 | 2014–2020 |
| Milbrae, California, US | 1 | 2018 |
| Millbrae, California, US | 1 | 2016 |